Clinical Trial Risk in Non-Hodgkin's Lymphoma: Endpoint and Target Selection

Purpose. To quantify the clinical trial risk of new drug development in Non-Hodgkin's lymphoma (NHL). Risk estimates for this disease have not been reported before. Methods. We undertook a retrospective review of clinical trials in (NHL) in four subtypes to compare the success rate with the ind...

Full description

Saved in:
Bibliographic Details
Main Authors: Jayson Lee Parker (Author), Zoe Yi Zhang (Author), Rena Buckstein (Author)
Format: Book
Published: Frontiers Media S.A., 2011-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available